ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
BONE MARROW BIOPSIES IN HEMATOLOGIC CANCERS: A SYSTEMATIC REVIEW OF PATIENT AND CAREGIVER BURDEN
Mar 18, 2026, 21:38 PM -
EVALUATING THE COST-EFFECTIVENESS OF PHARMACOGENETIC TESTING VIA THE MANTARA® PGX DNA TEST: INSIGHTS FROM NHS HEALTH CHECK INTEGRATION AND UK-BASED ECONOMIC MODELLING
Mar 18, 2026, 21:38 PM -
TRENDS IN PREECLAMPSIA PREVALENCE AND COMORBIDITY BURDEN AMONG PREGNANT WOMEN USING U.S. ADMINISTRATIVE CLAIMS DATA
Mar 18, 2026, 21:38 PM -
ADAPTING AGENTIC LARGE LANGUAGE MODELS (ALLM) TRAINED IN SOLID TUMORS FOR SYSTEMATIC LITERATURE REVIEW (SLR) IN HEMATOLOGICAL MALIGNANCIES: VALIDATION IN MULTIPLE MYELOMA (MM) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mar 18, 2026, 21:38 PM -
TIMING OF SERIOUS ADVERSE EVENTS FOLLOWING MIFEPRISTONE ABORTION IN US COMMERCIAL AND MEDICAID POPULATIONS
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF EXAGAMGLOGENE AUTOTEMCEL FOR PATIENTS WITH SICKLE CELL DISEASE AND RECURRENT VASO-OCCLUSIVE EVENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
INTEGRATING RCT AND RWD FOR LONG-TERM NEONATAL OUTCOME EVALUATION: LESSONS FROM THE PRIME STUDY
Mar 18, 2026, 21:38 PM -
EVOLUTION OF AI VALUE IN CHINESE CLINICAL PRACTICE: A 2025 SURVEY AND CASE SERIES ON PHYSICIAN-PRIORITIZED APPLICATIONS
Mar 18, 2026, 21:38 PM -
MIGRAINE BURDEN OF ILLNESS AMONG A COMMERCIALLY INSURED US POPULATION (IFORM-I)
Mar 18, 2026, 21:38 PM -
EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE
Mar 18, 2026, 21:38 PM -
EFFECT MODIFICATION BY MULTIMORBIDITY BURDEN ON THE EFFECTIVENESS AND SAFETY OF SGLT2 INHIBITORS IN OLDER ADULTS WITH T2D: A TARGET TRIAL EMULATION STUDY
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC LITERATURE REVIEW ON FINANCIAL BURDEN, FINANCIAL TOXICITY, OUTCOMES, POTENTIAL INTERVENTIONS, AND POLICIES ASSOCIATED WITH OUT-OF-POCKET MEDICATION AND HEALTHCARE EXPENSES AMONG OLDER PATIENTS IN THE US
Mar 18, 2026, 21:38 PM -
FROM MORTALITY TO MONEY: YEARS OF LIFE LOST AND THE ECONOMIC BURDEN OF CYSTIC FIBROSIS IN COLOMBIA (2005-2023)
Mar 18, 2026, 21:38 PM -
BRIDGING THE GAP: DEMOGRAPHIC REWEIGHTING OF REAL-WORLD SURVIVAL DATA VERSUS RCTS IN ACUTE MYELOID LEUKEMIA
Mar 18, 2026, 21:38 PM -
A SURVEY OF HEOR LEADERS IN PHARMA ON THE CHANGING US POLICY LANDSCAPE
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF INTRODUCING PCV20 IN COLOMBIAN PEDIATRIC POPULATION: A COST UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
EXAMINING THE EQUITY OF DISTRIBUTION OF GLP-1 PRESCRIPTIONS IN A LARGE URBAN PRIMARY CARE SYSTEM
Mar 18, 2026, 21:38 PM -
CHARACTERISTICS AND COMORBIDITIES INFLUENCING MORTALITY RISK AMONG PATIENTS WITH HEREDITARY ANGIOEDEMA
Mar 18, 2026, 21:38 PM -
DISCORDANCE IN MARKET SHARE PARAMETERS IN BUDGET IMPACT ANALYSES: A REVIEW OF SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Mar 18, 2026, 21:38 PM -
QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
Mar 18, 2026, 21:38 PM